—Dan Herendeen, research scientist, Tumor Vaccine Group, University of Washington
—Carmen Hertel, research associate, Unigen
—Jeff Hesselberg, vice president of regulatory affairs, GTx
—John Hill, director of medical sciences, Amgen
—Mark Hill, senior scientist in autoimmunity, ZymoGenetics
—Stephen Hill, executive director of manufacturing, Amgen
—Jim Hnilo, project manager, Ricerca Biosciences [Added: 10:10 am, 6/11/10]
—Nicole Hoagland, clinical study manager, Seattle Children’s Hospital
—Merl Hoekstra, vice president of corporate and business development, ELITech Group
—Patricia Hoffman, administrative director for research, Puget Sound Blood Center
—Ryan Holcomb, project director, Myriad Pharmaceuticals
—Mark Honda, director of human resources, CMC Icos
—Shawn Hooper, sales manager, Charles River Laboratories
—Monique Howard, senior associate scientist, Amgen
—Yvonne Howard, purchasing agent, Boeing
—Scott Hussell, senior research associate, Novo Nordisk
—Sally Thompson Iritani, associate director, ZymoGenetics
—Christopher Irons, contract biotech drug researcher
—Irina Jacobson, associate director of research chemistry, AVI Biopharma
—Laury Jenkins, executive assistant, CMC Icos
—Bohan Stan Jin, scientist II, Takeda San Diego
—Bryan Jones, biotech and pharmaceutical consultant
—Padmaja Juwadi, director of quality assurance, Dr. Reddy’s Laboratories [Added at 5:30 Pacific, 3/10/10]
—Suzanne Kanaly, scientific director, pathology, Allergan
—Ramesh Kasar, scientist
—Adam Kashishian, staff scientist at Calistoga Pharmaceuticals
—Heather Kean, administrative assistant, Seattle Genetics
—Kathy Keegan, principal scientist, Amgen
—Gary Keizur, director of quality assurance/quality control, MediQuest Therapeutics
—Michael Kellogg, associate director of facilities and operations, Trubion Pharmaceuticals
—Ed Kesicki, director of small molecule drug discovery, Infectious Disease Research Institute
—Pat Kilgannon, former director of project management, ZymoGenetics
—Musong Kim, research scientist, Gilead Sciences
—Jonathan Klepinger, senior research associate, Trubion Pharmaceuticals
